In the News

1855 News Items found
Luis Alberto Diaz Jr.
President Biden announced on September 15 his appointment of MSK medical oncologist and Head of the Division of Solid Tumor Oncology, Luis Alberto Diaz, Jr., MD, as one of seven distinguished members of the National Cancer Advisory Board.
Vanessa Rodriguez
Meet Vanessa Rodriguez, who is an event production manager in the Office of Development, where she works to enhance donor relationships to help fund cancer research.
MSK Kids neuroblastoma patient Abby Hawk
Get to know Abby Hawk, who got a tattoo of Memorial Sloan Kettering after being treated there for neuroblastoma.
Carol L. Brown, MD, Senior Vice President and Chief Health Equity Officer; Nicholls-Biondi Chair for Health Equity at MSK
MSK’s Chief Health Equity Officer, Carol Brown, MD, participated in a Fireside Chat on Health Equity for the Becker’s Healthcare Virtual Oncology Forum.
Omar Abdel-Wahab
Announcement
The Specialized Programs of Research Excellence (SPORE) grant will fund efforts focusing on the development of new treatments.
A collage of photos showing a zebrafish with GFP-labeled melanocytes, magnified GFP-labeled melanocytes, and hPSC-derived melanocytes growing in a dish.
Experiments with zebrafish and human pluripotent stem cells reveal the necessary ingredients, besides genetic mutations, that fuel the development of melanoma.
Computational biologist Quaid Morris
In the Lab
A new study shows how evolution and natural selection influence clonal hematopoiesis, an aging-related blood condition that increases the risk of blood cancer and cardiovascular disease.
MSK doctors and nurses
MSK ranked #15 across all companies and industries in New York State (NYS) and #2 in the NYS Healthcare & Social Industry.
MSK medical oncologist William Tap with Julian Fraser's family
It’s rare to meet someone who makes you want to be a better person. Cristy and Alec Fraser are those people — they are inspiring in an extraordinary and life-changing way.
MSK scientists Margaret Callahan, Ronglai Shen, and Katherine Panageas
A blood-based test identifies patients in whom immunotherapy may ‘LAG.’